Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
| Distributed by / for | Denton Pharma, Inc. |
| NDC | 70934-309-30 |
| Full product label | Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 30 count (NDC 70934-309-30); b) 60 count (NDC 70934-309-60); c) 90 count (70934-309-90); d) 120 count (NDC 70934-309-98) bottles, Rx Only, Time-Cap Labs Inc. Repackaged by Northwind Pharmaceuticals North Blenheim, NY 12131 |
| Recalling firm | Denton Pharma, Inc. |
| Distribution | Indiana - Nationwide. |
| Quantity | a) 684; b) 432; c) 3668; d) 2029 bottles |
| Recall initiated | 2020-10-08 |
| Report date | 2020-11-11 |
| Recall completed | — |
| Recall number | D-0057-2021 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | North Blenheim NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗